Nanjing Hailing Pharmaceutical

Nanjing Hailing Pharmaceutical, a core subsidiary of the Yangzijiang Pharmaceutical Group, is a specialized pharmaceutical company focused on the development and manufacturing of high-tech chemical drugs and modernized Traditional Chinese Medicines (TCM). Established in 2001 and based in Nanjing, the company serves as a vital R&D and production hub, operating the Nanjing Hailing Traditional Chinese Medicine Pharmaceutical Process Technology Research Institute. Its portfolio includes a wide range of therapeutic agents in gastroenterology, cardiology, and anti-infectives, with notable commercial products such as Lanpuzhou (Lansoprazole). The company integrates traditional medical heritage with modern clinical research and advanced process engineering to optimize drug delivery and therapeutic efficacy. Nanjing Hailing maintains significant manufacturing capabilities with GMP-certified facilities for multiple dosage forms including tablets, capsules, and granules.